| 81/237 | US=35 / Biol/Mol Lippman SM, Lee JJ. Cancer chemoprevention. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 711-20. ISBN 978-1-4160-3703-3. CANCER; QUIMIOPREVENCAO; PREVENCAO MOLECULAR-ALVO; BIOMARCADORES |
| 82/237 | US=23-C / Câncer Mano M, Machiels JP. Chemoradiation for rectal cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 357-73. ISBN 978-1-4020-9544-3. CANCER COLORRETAL; CANCER DE RETAL; CANCER DE RETO; TRATAMENTO; QUIMIOIRRADIACAO; QUIMIOIRRADIACAO PRE-OPERATORIO; QUIMIOIRRADIACAO POS-OPERATORIO; RADIACAO PRE-OPERATORIO; CITOTOXICIDADE; AGENTES BIOLOGICOS; CAPECITABINA; OXALIPLATINA; TERAPIA ALVO |
| 83/237 | US=30-A / Câncer HladniK LM, Wills AR, Augustin KM. Principles of systemic cancer therapy: molecular targeted therapy. In: Govindan R. The Washington manual of oncology. 2 nd. Philadelphia: J.B. Lippincott, 2008. p. 33-46. ISBN 978-1-5889-0323-0. TERAPIA DO CANCER SISTEMICO; TERAPIA-ALVO MOLECULAR; DOENCA TRATAVEL |
| 84/237 | US=27 / Imagem Johannes J, Gomella LG, Trabulsi EJ. Targeted therapies for localized prostate cancer: the urologist's perspective. In: Valicenti RK, Dicker AP, Jaffray DA. Image-guided radiation therapy of prostate cancer. New York: Informa Helthcare, 2008. p. 71-83. ISBN 978-1-420-06078-2. IMAGEM; CANCER DE PROSTATA; TERAPIAS-ALVO; CANCER DE PROSTATA LOCALIZADO; UROLOGISTA; CRIOTERAPIA; ULTRASSOM FOCALIZADO DE ALTA INTENSIDADE; RADIOTERAPIA |
| 85/237 | US=32 / Imagem Mah K, Caldwell CB. Biological target volume. In: Paulino AC, Teh BS. Pet-CT in radiotherapy treatment planning. Philadelphia: Saunders Elsevier, 2008. p. 52-89. ISBN 978-1-4160-3224-3. |
| 86/237 | US=33 / Gastro Kelsen DP, Van De Velde CJH, Minsky BD. Gastric cancer: clinical management. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 285-316. ISBN 978-0-7817-7617-2. CANCER GASTRICO; TRATAMENTO CLINICO; TRATAMENTO CIRURGICO; TERAPIA ADJUVANTE; IMUNOQUIMIOTERAPIA; QUIMIOTERAPIA NEOADJUVANTE; TERAPIA-ALVO |
| 87/237 | US=39 / Câncer Daniels TR, Neacato IL, Helguera G, Penichet ML. Targeting the transferrin receptor to overcome resistance to anti-cancer agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 13-27. ISBN 978-1-58829-989-5. RECEPTORES-ALVO; TRANSFERRINA; AGENTES ANTICANCERIGENOS; QUIMIORRESISTENCIA |
| 88/237 | US=47 / Câncer Knudsen ES, Braden WA. RB-pathway: cell control and cancer therapy. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 1-17. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. VIA RB; CONTROLE DO CANCER; TERAPIA CELULAR; SUPRESSOR DE TUMOR; RETINOBLASTOMA; CICLINAS; QUIMIOTERAPIA; TERAPIA DE ALVO MOLECULAR; CICLO CELULAR; E2F; ANTIMETABOLITOS; AGENTES ANTIMICROTUBULOS |
| 89/237 | US=64 / Câncer Heffner LT. Staging in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 3-7. (Comtemporary Hematology) ISBN 978-1-934115-82-4. MIELOMA MULTIPLO; TERAPIA-ALVO; MEDICINA TRADUCAO; BIOINFORMATICA; ACIDO TRANS-RETINOICO; GIST; IMATINIB; DASATINIBE; EPIGENETICA; DECITABINA; DETER HIPOTESE CELULAR |
| 90/237 | US=67 / Biol/Mol Neckers L, Ivy P. 17-AAG: targeting the molecular chaperone heat shock protein 90. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 75-95. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. 17-AAG; CHAPERONE; PROTEINA DE CHOQUE TERMICO 90; CANCER; CHAPERONE MOLECULAR; TERAPIA ALVO; PLASTICIDADE GENETICA; ONCOGENE; GELDANAMICINA; ANSAMICINA BENZOQUINONA |
| 91/237 | US=67 / Biol/Mol Wadler S. Molecular targeting in upper gastrointestinal malignancies. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 117-31. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. NEOPLASIAS GASTROINTESTINAIS SUPERIORES; SEGMENTACAO MOLECULAR; CARCINOMA HEPATOCELULAR; CANCER DE PANCREAS; CANCER DE ESTOMAGO; TERAPIA-ALVO |
| 92/237 | US=67 / Biol/Mol Schwartz JD, Llovet JM. Molecular targeting in hepatocellular carcinoma. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 165-210. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CARCINOMA HEPATOCELULAR; ALVO MOLECULAR; TERAPEUTICA ANTI-ANGIOGENESE; FATORES DE CRESCIMENTO |
| 93/237 | US=67 / Biol/Mol Goel A, Kozuch P. Molecularly targeted therapy in pancreatic cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 211-26. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER DE PANCREAS; TERAPIA ALVO MOLECULAR; BEVACIZUMABE; CETUXIMABE; ERLOTINIBE; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FATOR DE CRESCIMENTO VASCULAR ENDOTELIAL (VEGF); TERAPIA ANTI-ANGIOGENICA |
| 94/237 | US=67 / Biol/Mol Ho C, Davies AM, Lara PN, Gautschi O, Mach PC, Gumerlock PH, Gandara DR. Untargeted use of targeted therapy: a dilemma in non-small cell lung cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 227-40. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; TERAPIA-ALVO; EGFR; VEGF; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FATOR DE CRESCIMENTO VASCULAR ENDOTELIAL |
| 95/237 | US=67 / Biol/Mol Heath EI, Carducci MA. Targeted therapies for prostate cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 263-90. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER DE PROSTATA; TERAPIA-ALVO; INIBIDORES DA VIA DE SINALIZACAO; INIBIDORES DA ANGIOGENESE; IMUNOTERAPIA; AGENTES ANTI-TUBULINA; AGENTES ANTI-MITOTICOS; AGENTES DE SEGMENTACAO ANTI-VASCULARES |
| 96/237 | US=67 / Biol/Mol Atieh DM, Vahdat LT. Targeted therapy for beast cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 309-42. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER DE MAMA; TERAPIA-ALVO; TRASTUZUMABE; HER-2; MICROARRAY; BEVACIZUMABE; VEGF; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; LAPATINIBE; ANTICORPOS MONOCLONAIS; INIBIDOR DA TIROSINA QUINASE |
| 97/237 | US=67 / Biol/Mol Gupta A, Kirkwood JM. Melanoma. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 343-67. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. MELANOMA; PATOGENESE MOLECULAR; TERAPIA ALVO; INTERFERON; STAT; ANTISENSE BC12; BRAF; APOPTOSE; CICLO CELULAR |
| 98/237 | US=67 / Biol/Mol Nakamura T, Russell SJ. Engineering oncolytic measles viruses for targeted cancer therapy. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 431-45. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. VIRUS ONCOLITICOS; SARAMPO; TERAPIA DE CANCER; TERAPIA-ALVO; VIROTERAPIA |
| 99/237 | US=67 / Biol/Mol Dy GK, Adjei AA. Patient selection for rational development of novel anticancer agents. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 641-8. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. AGENTES ANTICANCERIGENOS; SELECAO DOS PACIENTES; TERAPIA-ALVO; BIOMARCADORES; EXPRESSAO GENICA; AMPLIFICACAO GENICA |
| 100/237 | US=67 / Biol/Mol Chen HX, Dancey JE. Combinations of molecular-targeted therapies: opportunities and challenges. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 693-705. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. |